Literature DB >> 18642063

Effect of cyclodextrin complexation on the liposome permeability of a model hydrophobic weak Acid.

Vijay Joguparthi1, Bradley D Anderson.   

Abstract

PURPOSE: This study examines the effect of a chemically modified beta-cyclodextrin on the liposome bilayer permeability of a liposomally entrapped model hydrophobic weak acid, DB-67 (7-t-butyldimethylsilyl-10-hydroxycamptothecin).
MATERIALS AND METHODS: Permeability studies were conducted in liposomes prepared by hydration-extrusion in the presence or absence of entrapped hydroxypropyl-beta-cyclodextrin (HPbetaCD). A gradient HPLC method with evaporative light scattering detection was developed for analysis of HPbetaCD. DB-67 was analyzed by HPLC with fluorescence detection.
RESULTS: HPbetaCD entrapped in the aqueous compartment of liposomes was found to be membrane impermeable. Gel phase liposomes were stable in the presence of HPbetaCD. HPbetaCD complexation did not significantly alter the apparent permeability of DB67 lactone, due to its high membrane binding. However, lactone ring-opening and ionization significantly decreased the apparent permeability and improved the liposomal retention of DB-67, an effect that was amplified in the presence of 50 mM HPbetaCD.
CONCLUSIONS: In liposomes, cyclodextrin complexation competes with liposomal membrane binding which may temper the potential benefit of complexation in prolonging hydrophobic drug retention. Cyclodextrin complexation combined with drug ionization may nevertheless significantly enhance the retention of ionizable hydrophobic drugs in liposomes as complexation may compete more favorably with membrane binding when the drug is ionized.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18642063     DOI: 10.1007/s11095-008-9664-6

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  25 in total

1.  Insertion of poly(ethylene glycol) derivatized phospholipid into pre-formed liposomes results in prolonged in vivo circulation time.

Authors:  P S Uster; T M Allen; B E Daniel; C J Mendez; M S Newman; G Z Zhu
Journal:  FEBS Lett       Date:  1996-05-20       Impact factor: 4.124

2.  Betamethasone-in-cyclodextrin-in-liposome: the effect of cyclodextrins on encapsulation efficiency and release kinetics.

Authors:  Géraldine Piel; Marie Piette; Valery Barillaro; Delphine Castagne; Brigitte Evrard; Luc Delattre
Journal:  Int J Pharm       Date:  2006-02-07       Impact factor: 5.875

3.  Integrity of liposomes in presence of cyclodextrins: effect of liposome type and lipid composition.

Authors:  Panayiota Hatzi; Spyridon Mourtas; Pavlos G Klepetsanis; Sophia G Antimisiaris
Journal:  Int J Pharm       Date:  2006-10-10       Impact factor: 5.875

4.  On the mechanism of topoisomerase I inhibition by camptothecin: evidence for binding to an enzyme-DNA complex.

Authors:  R P Hertzberg; M J Caranfa; S M Hecht
Journal:  Biochemistry       Date:  1989-05-30       Impact factor: 3.162

Review 5.  Entrapment of cyclodextrin-drug complexes into liposomes: potential advantages in drug delivery.

Authors:  B McCormack; G Gregoriadis
Journal:  J Drug Target       Date:  1994       Impact factor: 5.121

6.  Study of the relationship between lipid binding properties of cyclodextrins and their effect on the integrity of liposomes.

Authors:  G Piel; M Piette; V Barillaro; D Castagne; B Evrard; L Delattre
Journal:  Int J Pharm       Date:  2007-01-19       Impact factor: 5.875

7.  Factors influencing uptake and retention of amino-containing drugs in large unilamellar vesicles exhibiting transmembrane pH gradients.

Authors:  E Maurer-Spurej; K F Wong; N Maurer; D B Fenske; P R Cullis
Journal:  Biochim Biophys Acta       Date:  1999-01-12

8.  Liposomal delivery of hydrophobic weak acids: enhancement of drug retention using a high intraliposomal pH.

Authors:  Vijay Joguparthi; Bradley D Anderson
Journal:  J Pharm Sci       Date:  2008-01       Impact factor: 3.534

9.  Efficacies of cyclodextrin-complexed and liposome-encapsulated clarithromycin against Mycobacterium avium complex infection in human macrophages.

Authors:  Isam Ismail Salem; Nejat Düzgünes
Journal:  Int J Pharm       Date:  2003-01-16       Impact factor: 5.875

10.  Transmembrane gradient driven phase transitions within vesicles: lessons for drug delivery.

Authors:  D D Lasic; B Ceh; M C Stuart; L Guo; P M Frederik; Y Barenholz
Journal:  Biochim Biophys Acta       Date:  1995-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.